Overview of Gonol

Quick Facts

Property	Description
Active ingredients	Ampicillin, Probenecid
Form	Tablet, Capsule, Injectable Solution
Pharmacological class	beta-Lactam Antibiotic (Aminopenicillin) and Antibiotic Adjunct
Common use (General)	Treatment of bacterial infections
Origin	Semi-synthetic (Ampicillin) and Synthetic (Probenecid)

What is Gonol and How is it Classified?

Gonol is a combination pharmaceutical product classified as a prescription-only drug, defined by the inclusion of the antibiotic Ampicillin and the pharmacokinetic agent Probenecid. This medication is broadly classified as a beta-lactam antibiotic, specifically an aminopenicillin, but the addition of Probenecid qualifies it as an antibiotic adjunct. This structure is a specific differentiating factor, as it is designed not to enhance the antibiotic's action against the bacteria but against the body's natural clearance processes.

The Pharmacokinetic Enhancement

The two active ingredients operate in a synchronized manner: Ampicillin acts as the primary bactericidal agent. Ampicillin is a key semi-synthetic penicillin used widely to treat susceptible bacterial infections. Probenecid, a synthetic renal tubular transport blocking agent, intentionally interferes with the kidneys' ability to excrete Ampicillin. Probenecid works in this way to increase the levels of other medicines in the body. This controlled mechanism ensures the therapeutic concentration of the antibiotic is sustained at higher levels for a longer duration.

Forms and General Therapeutic Purpose

Gonol is supplied primarily as an oral preparation (such as a tablet or capsule), making it suitable for outpatient use, though parenteral injection forms may be used in clinical settings. The general therapeutic purpose is to treat various bacterial infections by maximizing the effective concentration of the antimicrobial agent over time. This dual-agent strategy offers a clear benefit over rapidly cleared single-agent antibiotics by providing more robust and sustained systemic exposure.

Regulatory References

What side effects are possible with Gonol?

Possible Side Effects and Safety Information

The safety profile of Gonol, a combination of Ampicillin and Probenecid, reflects the documented risks of both active components, with particular attention to how Probenecid's effect may increase Ampicillin's concentration.

Adverse Reactions by Classification

The most significant safety concern is the risk of fatal hypersensitivity (anaphylactoid) reactions, a severe warning associated with the penicillin class, including Ampicillin. Gastrointestinal and dermatological issues are also commonly documented.

Classification	Examples of Officially Documented Adverse Reactions
Common	Diarrhea, nausea, vomiting, and generalized skin rash.
Rarely Documented	Anaphylaxis, pseudomembranous colitis, serious cutaneous reactions (SJS/TEN), hepatitis, interstitial nephritis, and hematological changes like aplastic anemia.

Adverse effects are officially categorized across various System-Organ Classes (SOCs), including immune system, gastrointestinal, skin and subcutaneous tissue, blood and lymphatic, and renal/urinary disorders.

Safety Restrictions and Constraints

The medication is contraindicated in individuals with a known history of hypersensitivity to any penicillin. Population-specific safety notes formally restrict use in certain groups. For instance, the Probenecid component is contraindicated in children under two years of age, and its use is generally not recommended in patients with significant renal impairment.

Regulatory safety information notes that the combination mechanism, which leads to sustained high plasma concentrations of Ampicillin, may result in an increased incidence of Ampicillin-related adverse reactions.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documents describe specific manifestations and required actions for a suspected overdose of Gonol.

Category	Documented Regulatory Statement
Documented Manifestations	Symptoms include nausea, vomiting, and diarrhea. Central Nervous System (CNS) toxicity is officially reported, primarily manifesting as convulsions (seizures) and confusion.
Severe Outcomes	Life-threatening hypersensitivity (anaphylaxis) is a possibility, along with serious complications such as fatal colitis (C. difficile-associated diarrhea). Hepatic dysfunction is also a documented risk.
High-Risk Patient Note	Patients with impaired renal function face an increased risk of Ampicillin accumulation and neurotoxicity due to reduced drug clearance.

Required Emergency Actions

Action Mandate	Regulatory Phrasing
Urgent Help Required	Seek emergency medical attention immediately. Call emergency services if the patient has collapsed, experienced a seizure, or is struggling to breathe.
Antidote/Management	No specific chemical antidote is known. Management relies upon symptomatic and supportive treatment, including necessary fluid and electrolyte management. The drug may be removed from circulation via haemodialysis.

The regulatory profile mandates that medication should be discontinued at the onset of suspected overdose, and immediate emergency intervention is required due to the potential for severe CNS or anaphylactic reactions.

Therapeutic Uses of Gonol

What Gonol Treats: Main Uses and Benefits

Gonol, a combination antibiotic treatment, is used in situations involving certain distressing symptoms of bacterial infection. Its primary component is commonly used to manage infections across several critical body systems. Gonol may assist with managing symptoms related to systemic imbalance, such as fever and malaise, associated with conditions that present with systemic or localized discomfort. These include infections of the genitourinary, respiratory tracts, and skin/soft tissues, and the management of uncomplicated gonorrhea (caused by susceptible strains).

Therapeutic Focus and Benefit

Gonol is applied across domains where additional symptomatic support is needed in conditions associated with acute or disruptive episodes. It helps address symptom clusters that may become intense or disruptive, such as localized pain, inflammation, or discomfort that interferes with daily functioning. The primary goal of this therapy is to provide supportive, sustained antibacterial action to assist with the goal of bacterial clearance in acute symptomatic episodes. This sustained concentration supports patients by assisting with maintaining functional stability, which may assist with managing symptom recurrence.

Quick Fact: Relief for Systemic Discomfort

Gonol supports the management of symptoms related to systemic imbalance, such as fever and generalized malaise, by addressing the underlying bacterial cause and contributing to improved comfort during periods of heightened symptoms.

Eligibility and Restrictions for Use

Population Eligibility and Contraindications

The official regulatory profile for Gonol defines strict eligibility criteria based on the risks associated with its Ampicillin and Probenecid components. The core determination for who can and cannot use Gonol is based on documented contraindications and population restrictions.

Absolute Contraindications (Must Not Use)

Use is prohibited for individuals with a history of hypersensitivity to any penicillin drug or to Probenecid. The medicine must not be administered to children under two years of age, as Probenecid is explicitly contraindicated in this age group. Contraindications also extend to patients with known blood dyscrasias or those with a history of uric acid kidney stones.

Restricted or Conditional Use

Eligibility is restricted for several populations. The medicine is not recommended for patients with severe renal impairment due to the component that relies on kidney function for efficacy and clearance. Use is also not recommended in patients with infectious mononucleosis. For pregnant women, use is generally restricted, and the decision requires a careful assessment of benefit versus risk due to limited official safety data. Caution is advised for older adults, often requiring evaluation due to potential age-related decline in organ function.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Formal Regulatory Restrictions

Classification	Interacting Agent
Contraindicated	Salicylates (e.g., Aspirin)
Contraindicated	Ketorolac
Not Recommended	Concomitant use with a penicillin in the presence of Known Renal Impairment (GFR le 30 mL/minute)

The interaction profile for Gonol is defined by the Probenecid component, which inhibits the renal tubular secretion of many compounds, including the Ampicillin component. This mechanism, driven by competitive inhibition of Organic Anion Transporters (OATs), decreases the renal clearance of co-administered drugs.

Exposure-Modifying Interactions

This reduction in clearance leads to increased plasma concentrations of numerous agents, including Methotrexate and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) such as Indomethacin and Naproxen. The co-administration is also documented to increase the half-life of Acetaminophen and certain Antivirals (e.g., Acyclovir, Ganciclovir).

Mechanism of Action

Blocking Bacterial Cell Wall Construction

Gonol operates through a coordinated dual-mechanism, beginning with Ampicillin's direct anti-pathogenic action. Ampicillin functions as an irreversible inhibitor by binding to Penicillin-Binding Proteins (PBPs), which are the essential bacterial enzymes responsible for synthesizing the rigid cell wall. This molecular blockade prevents the necessary cross-linking of the peptidoglycan layer. This mechanistic cascade results directly in the breakdown and lysis (destruction) of the susceptible organism's cellular structure.

Sustaining Effective Levels via Renal Pathway Modulation

Probenecid, the adjunct component, complements the primary action by targeting the body's renal clearance pathway. Probenecid acts as a competitive inhibitor of Organic Anion Transporters (OATs), primarily OAT1 and OAT3, located in the renal tubules. Blocking these transporters slows down the active removal of Ampicillin from the bloodstream. This physiological modulation results in a sustained and higher concentration of the antibiotic in the systemic circulation for a prolonged period, which maintains the conditions required for maximal PBP inhibition.

Dosage and Administration Information

How Gonol is Used

The usage of Gonol, a combination of Ampicillin and Probenecid, is defined by a specific, high-level administration protocol designed for acute use. The combination is primarily administered via the oral route in the form of tablets or capsules. The Probenecid component serves to enhance the antibiotic's concentration in the body by interfering with the kidneys' clearance process.

Official Dosing and Administration

The standard adult regimen involves a single, one-time treatment course where the two components must be taken simultaneously.

Instruction	Detail
Route of Administration	Oral
Standard Single Dose	3.5 g Ampicillin with 1 g Probenecid
Frequency	Single-dose (one-time administration)

Procedural and Population Rules

For the oral dosage form to be properly absorbed, official guidelines specify that the medicine should be taken on an empty stomach, generally defined as either 30 minutes before or 2 hours after a meal.

Regarding specific populations, the combination regimen is approved for patients weighing over 20 kg. Dose adjustments for the Ampicillin component are typically required for individuals with renal impairment (impaired kidney function) to safely modify the time interval between doses. Furthermore, the Probenecid component is restricted for use in children under two years of age.

This structured, one-time administration pattern constitutes the core of the official usage protocol.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Gonol

Evidence for Use in Uncomplicated Gonorrhea

Gonol, the combination of ampicillin and probenecid, has been evaluated in research exploring uncomplicated gonorrhea, a condition characterized by fluctuating or episodic manifestations. The primary research consists of Randomized Controlled Trials (RCTs) and systematic reviews that compared this combination to other treatment regimens studied. Researchers focused on adult populations presenting with localized infections in the genital, anal, or urethral sites.

The main outcomes linked to inflammatory or irritative states and the presence of the pathogen was observed. Specifically, studies examined the rate of microbiological clearance, which refers to the absence of the targeted pathogen reported at a follow-up visit, and the rate of clinical cure, which is the resolution of the acute signs and symptoms. Findings describe patterns observed in the studies related to these microbiological and clinical outcomes shortly after treatment.

Research on Pharmacokinetic Enhancement and Drug Levels

A separate area of research explores the drug’s design, focusing on the two ingredients working together. These studies, primarily pharmacokinetic (PK) studies using a crossover design, were conducted in healthy adult volunteers. Research examined the maximum concentration (Cmax) and the time the drug remained in the bloodstream (AUC) for ampicillin.

The evidence describing this enhancement is generally observed across studies, though its clinical relevance has limitations. Comparative evidence is lacking that directly links this measured increase in drug level to outcomes related to physical discomfort in a wide range of patient populations. The studies primarily focused on healthy adult volunteers. Research highlights that the results apply only to the populations studied, and data for specific acutely ill patient groups remain insufficient.

What is Still Uncertain About the Research

Several aspects of the evidence landscape are still emerging or not fully established in the scientific literature. Limited information is available from recent head-to-head comparative trials testing the Gonol combination against all new single-agent alternatives that are currently in wide use. This lack of updated comparative evidence contributes to uncertainty.

Furthermore, research describes that the measured effect on outcomes reflecting daily functioning or activity level is mostly inferred from the rate of microbiological clearance, rather than from specific functional or quality-of-life assessments. Findings describe group patterns, not personal outcomes, and the evidence quality varies across studies, particularly for the non-gonococcal indications.

Key Studies & References

Probenecid (MedlinePlus Drug Information)

Frequently Asked Questions (FAQ)

Common questions about Gonol (FAQ)

Q: How long does Gonol stay in the body after the last dose?

Regulatory documents indicate that the duration of the component Ampicillin in the body is extended due to the action of Probenecid. This is because Probenecid works by decreasing the rate at which Ampicillin is eliminated, or cleared, by the kidneys, which helps sustain the necessary concentration of the antibiotic.

Q: What does it mean if Gonol has a 'Black Box Warning'?

The term 'Black Box Warning' refers to the most serious type of safety warning required by the FDA on a medicine’s labeling. It is used to call immediate attention to specific, severe, or potentially life-threatening risks. For penicillin-class drugs like one component of Gonol, this warning is generally related to the risk of fatal hypersensitivity (allergic) reactions.

Q: What are the common signs of an allergic reaction to Gonol?

Official information describes that the signs of an immediate allergic reaction can include a rash, hives (urticaria), and swelling of the throat or face. In rare instances, it can involve a life-threatening, severe reaction known as anaphylaxis, a severe reaction that has been documented in official warnings.

Q: Can Gonol affect sleep?

Some official product information notes that certain side effects, such as restlessness or insomnia (difficulty sleeping), may be associated with the components of Gonol on rare occasions. Official documentation describes the occurrence of these reactions, which informs professional guidance.

Q: Is Gonol suitable for older adults?

Official labeling includes information regarding the use of Gonol in geriatric patients (older adults). The labeling notes that kidney function is a key consideration for the Ampicillin component dosage in this population, which is commonly monitored by healthcare providers.

Q: Are there any special considerations for using Gonol in women who are pregnant or nursing?

Yes. Regulatory documents contain specific safety notes and classification data regarding the use of both Ampicillin and Probenecid during pregnancy and while breastfeeding. This information describes potential risks and is used by healthcare professionals to guide decisions for these specific populations.

Q: Why do some official sources list multiple conditions for Gonol?

Regulatory documents list all conditions, known as Therapeutic Indications, for which the product has received official authorization. This authorization is granted based on clinical data that was reviewed and approved by the health authority (such as the EMA or FDA) for demonstrating safety and effectiveness for those uses.

Q: Is Gonol considered a controlled substance?

Official drug schedules and regulatory listings, such as those maintained by the DEA in the US, indicate that the active components of Gonol, Ampicillin and Probenecid, are not generally classified as controlled substances.

Q: Does Gonol have a warning about driving or operating machinery?

Some official product information contains statements regarding potential impairment of driving or operating heavy machinery. This statement is often included because of the possibility of certain side effects like dizziness or confusion that could affect motor function or reaction time.

Q: Why is Gonol available only by prescription?

Medicines like Gonol are classified as prescription-only because they require the expertise of a medical professional to diagnose the condition, safely manage administration, and monitor potential risks.

Q: Does Gonol have any listed interactions with herbal products?

Regulatory documents may contain a general statement noting that interactions with unlisted agents, which can include herbal supplements or non-prescription products, have not been fully studied or documented in the same detail as prescription drugs. This underscores the need for medical professionals to have complete information on all products a patient is taking.

Q: How do I know if a side effect is listed in the official documents for Gonol?

The official source for this information is the full prescribing information (often called the SmPC or DailyMed document) or the patient information leaflet that comes with the medicine. These documents describe all reactions that were documented in clinical studies and during post-marketing surveillance.

Q: Can Gonol affect laboratory test results?

Yes, regulatory texts include specific warnings that the components of Gonol, Ampicillin or Probenecid, may interfere with the results of certain laboratory tests. For example, they are known to affect some types of tests used for measuring urine glucose (sugar) levels.

Q: What is the risk of dependence or withdrawal with Gonol?

The regulatory label includes a section on abuse and dependence. According to official data, the components of Gonol, Ampicillin and Probenecid, have not been associated with dependence in their clinical use.

Q: Why is my doctor concerned about my liver function before prescribing Gonol?

Official documents list hepatitis (inflammation of the liver) as a rarely documented adverse reaction to the medication. This documented risk may prompt a medical professional to exercise caution or screen for pre-existing liver conditions, even though the primary safety concern is typically related to kidney function.

Q: Can Gonol be crushed or cut?

The manufacturer's Patient Information Leaflet or the official regulatory section on administration specifies how the medicine should be taken. This information indicates whether the tablet or capsule form is intended to be swallowed whole to ensure the medicine is properly delivered and absorbed by the body.

Q: Is there a patient brochure available for Gonol from the manufacturer?

Official regulatory documents, such as the full prescribing information provided by the FDA, typically include a separate section or a link for accessing the patient-friendly leaflet or Patient Information section. This brochure contains key safety and usage details in plain language.

How should Gonol be stored and disposed of?

How to Store and Dispose of GONOL

The storage and disposal instructions for GONOL (Ampicillin and Probenecid) must adhere strictly to official regulatory labeling to maintain stability and ensure safety.

Storage Requirements

Oral forms must be stored at Controlled Room Temperature (20 C to 25 C) in a tightly closed container and protected from excess moisture. The dry injectable powder also requires Controlled Room Temperature storage. The reconstituted injectable solution must not be frozen and has a strictly time-limited stability, which may require refrigeration for a few hours or days depending on the preparation. All forms must be stored out of the sight and reach of children.

Disposal Instructions

Used needles and syringes from the injectable form must be immediately placed in an FDA-cleared sharps disposal container. Unused or expired oral medication should not be flushed down a toilet; instead, it must be mixed with an undesirable substance and placed in a sealed bag before being disposed of in the household trash.

Gonol